109 related articles for article (PubMed ID: 21115120)
1. Selective impairment of CD4+CD25+Foxp3+ regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosis.
Liu N; Zheng Y; Zhu Y; Xiong S; Chu Y
Int Immunopharmacol; 2011 Feb; 11(2):212-9. PubMed ID: 21115120
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
3. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
4. CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.
Zhu Y; Liu N; Xiong SD; Zheng YJ; Chu YW
Scand J Immunol; 2011 Apr; 73(4):301-8. PubMed ID: 21223350
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
7. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice.
Shima T; Sasaki Y; Itoh M; Nakashima A; Ishii N; Sugamura K; Saito S
J Reprod Immunol; 2010 Jun; 85(2):121-9. PubMed ID: 20439117
[TBL] [Abstract][Full Text] [Related]
9. Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice.
Qu Y; Jin S; Zhang A; Zhang B; Shi X; Wang J; Zhao Y
Radiat Res; 2010 Feb; 173(2):148-57. PubMed ID: 20095846
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
11. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
[TBL] [Abstract][Full Text] [Related]
12. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
13. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
[TBL] [Abstract][Full Text] [Related]
15. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy.
Zhang L; Dermawan K; Jin M; Liu R; Zheng H; Xu L; Zhang Y; Cai Y; Chu Y; Xiong S
Clin Immunol; 2008 Nov; 129(2):219-29. PubMed ID: 18771959
[TBL] [Abstract][Full Text] [Related]
16. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
18. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
[TBL] [Abstract][Full Text] [Related]
19. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells.
Liu Z; Zhang C; Sun J
Biochem Biophys Res Commun; 2010 Sep; 400(3):409-12. PubMed ID: 20801101
[TBL] [Abstract][Full Text] [Related]
20. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
